197 related articles for article (PubMed ID: 34116934)
1. Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer.
Rajwa P; Schuettfort VM; D'Andrea D; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Huebner N; Aulitzky A; Mun DH; Briganti A; Karakiewicz PI; Fajkovic H; Shariat SF
Urol Oncol; 2021 Nov; 39(11):785.e19-785.e27. PubMed ID: 34116934
[TBL] [Abstract][Full Text] [Related]
2. Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy.
Grossmann NC; Schuettfort VM; Pradere B; Rajwa P; Quhal F; Mostafaei H; Laukhtina E; Mori K; Motlagh RS; Aydh A; Katayama S; Moschini M; Fankhauser CD; Hermanns T; Abufaraj M; Mun DH; Zimmermann K; Fajkovic H; Haydter M; Shariat SF
Urol Oncol; 2022 Mar; 40(3):106.e11-106.e19. PubMed ID: 34810077
[TBL] [Abstract][Full Text] [Related]
3. Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy.
Rajwa P; Schuettfort VM; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Aulitzky A; Paradysz A; Karakiewicz PI; Fajkovic H; Zimmermann K; Heidenreich A; Gontero P; Shariat SF
World J Urol; 2021 Oct; 39(10):3771-3779. PubMed ID: 33997919
[TBL] [Abstract][Full Text] [Related]
4. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
Front Oncol; 2022; 12():907625. PubMed ID: 35719913
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy.
D'Andrea D; Soria F; Abufaraj M; Gust K; Foerster B; Vartolomei MD; Kimura S; Mari A; Briganti A; Remzi M; Seitz CK; Mathieu R; Karakiewicz PI; Shariat SF
Urol Oncol; 2018 Dec; 36(12):528.e7-528.e13. PubMed ID: 30446461
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of systematic immune-inflammation index combined with Ki-67 index on prognosis of prostate cancer patients after laparoscopic radical prostatectomy.
Wu R; Hu M; Zhang P
BMC Urol; 2023 Dec; 23(1):210. PubMed ID: 38114926
[TBL] [Abstract][Full Text] [Related]
7. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
8. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
9. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
Laukhtina E; Pradere B; D'Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Enikeev D; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):329-336. PubMed ID: 33769012
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.
Sevcenco S; Mathieu R; Baltzer P; Klatte T; Fajkovic H; Seitz C; Karakiewicz PI; Rouprêt M; Rink M; Kluth L; Trinh QD; Loidl W; Briganti A; Scherr DS; Shariat SF
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):163-7. PubMed ID: 26810014
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
[TBL] [Abstract][Full Text] [Related]
14. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.
Yamoah K; Zeigler-Johnson CM; Jeffers A; Malkowicz B; Spangler E; Park JY; Whittemore A; Rebbeck TR
BMC Cancer; 2016 Jul; 16():557. PubMed ID: 27473687
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
Mori K; Resch I; Miura N; Laukhtina E; Schuettfort VM; Pradere B; Katayama S; D'Andrea D; Kardoust Parizi M; Abufaraj M; Fukuokaya W; Collà Ruvolo C; Luzzago S; Knipper S; Palumbo C; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Egawa S; Shariat SF
Cancer Immunol Immunother; 2021 Sep; 70(9):2641-2650. PubMed ID: 33591412
[TBL] [Abstract][Full Text] [Related]
16. Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Yousefi K; Davicioni E; Ghadessi M; Johnson MH; Sundi D; Tosoian JJ; Han M; Humphreys EB; Partin AW; Walsh PC; Trock BJ; Schaeffer EM
Eur Urol; 2016 Mar; 69(3):496-504. PubMed ID: 25922274
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer.
Katayama S; Mori K; Pradere B; Laukhtina E; Schuettfort VM; Quhal F; Motlagh RS; Mostafaei H; Grossmann NC; Rajwa P; Moschini M; Mathieu R; Abufaraj M; D'Andrea D; Compérat E; Haydter M; Egawa S; Nasu Y; Shariat SF;
World J Urol; 2021 Dec; 39(12):4355-4361. PubMed ID: 34143284
[TBL] [Abstract][Full Text] [Related]
19. Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.
Maj-Hes AB; Mathieu R; Özsoy M; Soria F; Moschini M; Abufaraj M; Briganti A; Roupret M; Karakiewicz PI; Klatte T; Shariat SF
Urol Oncol; 2017 Jul; 35(7):460.e1-460.e8. PubMed ID: 28460801
[TBL] [Abstract][Full Text] [Related]
20. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G
Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
